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Brief Communications
Sleep Modulation Alleviates Axonal Damage and Cognitive
Decline after Rodent Traumatic Brain Injury
XMarta M. Morawska,* Fabian Bu¨chele,* Carlos Goncalves Moreira, Lukas L. Imbach, Daniela Noain,‡
and Christian R. Baumann‡
Department of Neurology, University Hospital of Zurich, 8091 Zurich, Switzerland
Traumatic brain injury (TBI) is a major cause of death and disability worldwide. It produces diffuse axonal injury (DAI), which contrib-
utes to cognitive impairment, but effective disease-modifying treatment strategies are missing. We have recently developed a rat model
of closed skull TBI that reproduces humanTBI consequences, includingDAI and clinical sequelae such asmemory impairment. Here, we
investigated whether sleep modulation after trauma has an impact on DAI andmemory outcome. We assessed cognition with the novel
object recognition test and stained for amyloid precursor protein, a DAI marker. We found that both sleep induction and restriction
acutely after TBI enhanced encephalographic slow-wave activity, markedly reduced diffuse axonal damage in the cortex and hippocam-
pus, and improvedmemory impairment 2weeks after trauma. These results suggest that enhancing slow-wave sleep acutely after trauma
may have a beneficial disease-modifying effect in subjects with acute TBI.
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Introduction
Traumatic brain injury (TBI) is a major public health concern
affecting12% of the general population worldwide and result-
ing in high rates of death anddisability. Themost common causes
of TBI include violence, vehicle accidents, and falls (Styrke et al.,
2007). TBI is currently interpreted as a disease process (Masel and
DeWitt, 2010), presenting not only with acute manifestations,
but also with long-lasting symptoms, potentially originated by
progressive axonal injury (Bramlett andDietrich, 2002, Inglese et
al., 2005). Studies suggest that diffuse axonal injury (DAI) is an
important contributor to posttraumatic cognitive impairment
(Li et al., 2006, Kraus et al., 2007, Rostami et al., 2012), which is
one of the most prevalent symptoms after TBI (Hall et al., 2005).
Immunoreactivity to APP has been established as a gold standard
for the detection of DAI. In addition to APP, pathological mole-
cules that are linked to enhanced endoplasmic reticulum (ER)
stress and to unfolded protein response, both of which are asso-
ciated with neuronal death and with neurodegenerative disor-
ders, have also been found to accumulate in the traumatized
brain. Among these are activating transcription factor 4 (ATF-4),
an ER stress marker, and ubiquitin (UB), a small regulatory pro-
tein playing a role in degradation of other proteins (Begum et al.,
2014). Potentially noxious molecules are cleared via glymphatic
pathways in the brain (Iliff et al., 2014, Plog et al., 2015), partic-
ularly during sleep and anesthesia, which are both characterized
by predominant slow-wave activity (Xie et al., 2013). Indeed,
there is an emerging discussion that sleep might serve as a poten-
tial treatment for a number of neurological conditions. Sleep
restriction, resulting in increased slow-wave activity during sub-
sequent rebound sleep (Borbe´ly et al., 1984, Franken et al., 1991),
has been suggested to be beneficial for TBI (Martinez-Vargas et
al., 2012) and stroke subjects (Cam et al., 2013). However, not
only physiological sleep, but also pharmacological interventions
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Significance Statement
Traumatic brain injury (TBI) is a clinically important entity. Cognitive deficits belong to themost prevalent chronic posttraumatic
symptoms, most likely due to diffuse axonal injury (DAI). A growing body of evidence suggests a role of sleep in the clearance of
waste products in the brain, possibly including amyloid precursor protein (APP), a marker of DAI. In this study, we provide
evidence that enhancement of slow-wave oscillatory activity in the delta-frequency range decreases the APP-immunoreactivity
and preserves cognitive abilities after trauma, potentially offering novel, noninvasive treatment options for traumatic injury.
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aimed at increasing slow oscillatory encephalographic activity,
were linked to APP clearance in an Alzheimer’s disease model
(Klein et al., 2015) and similar interventions also improved out-
come after stroke in rodents (Gao et al., 2008). Therefore, there is
increasing evidence that interventions that enhance slow-wave
activity could constitute novel, noninvasive treatment options
for acute and chronic neurological conditions.
In this study, we aimed to assess whether sleep modulation
procedures that induce increased slow-wave immediately after
trauma improve diffuse axonal damage and TBI-induced cogni-
tive deficits in a rat model of TBI.
Materials andMethods
Animals. We used male Sprague Dawley rats (Charles River) weighing
230–270 g and housed them in groups before interventions; afterward,
we single housed them with food and water available ad libitum. The
animal room temperature was constantly maintained at 21–22°C and
animals were kept on a 12 h light/dark cycle starting at 8:00 or 9:00 A.M.
according to season. All experiments were approved by the veterinary
office of the Canton Zurich and conducted according to the local guide-
lines for the care and use of laboratory animals.
Surgeries.We performed all surgical procedures under deep anesthesia
by inhalation of isoflurane (4.5% for induction, 2.5% for maintenance)
and subsequent analgesia with buprenorphine (0.05 mg/kg, s.c.). We
monitored animals daily over the first week after surgeries and weekly
thereafter.
EEG/EMG headset implantation. Implantation of EEG/EMG electrodes
was performed as described previously (Buchele et al., 2015).
TBI. After 8–10 d of recovery, rats weighed 300–350 g and underwent
closed skull TBI in the prefrontocortical area of the brain using the
adapted weight-drop model (Buchele et al., 2015). In sham animals, all
procedures were identical except for the traumatic hit.
Cardiac perfusion. Thirty days after TBI or sham procedures, animals
underwent cardiac perfusion as described previously (Buchele et al.,
2015). We immediately harvested the brains for histological evaluations.
After perfusion, brains were cryoprotected by sequential sucrose steps,
frozen in dry ice, and finally stored at80°C until further use.
Behavior: novel object recognition test. All animals underwent behav-
ioral testing at baseline and 14 d after sham or TBI (Fig. 1A) to assess the
effect of sleep modulation on posttraumatic memory impairment. To
examine declarative memory performance, we used the novel object rec-
ognition test as described previously (Ennaceur and Delacour, 1988, Bu-
chele et al., 2015). We manually scored video-recorded exploratory
behavior and calculated the preference ratio, defined as time spent on
exploration of a novel object relative to the total exploration time of both
objects, for each group and time point tested and compared it against
chance performance (0.5) using a one-sample t test. Animals showing
signs of anxiety (n 2) were excluded from analysis.
Sleep modulation interventions. To evaluate the effect of sleep modula-
tion on histological outcome and memory performance, we divided 25
sham and 25 TBI animals into three groups. Each group received two
intraperitoneal injections per day (1 h after lights on and 1 h after lights
off). The control (Ctrl) and sleep-restricted (SR) groups were treated
with saline and the sleep-induced (SI) group was treated with sodium
oxybate (SO; Xyrem-GHB salt, 400 mg/kg; UCB Pharma) (Lettieri and
Fung, 1979, Nava et al., 2001). We performed sleep restriction by gentle
handling (6 h daily, starting at 2 h after lights on; Tobler and Jaggi, 1987).
Figure 1. Sleepmodulation after TBI.A, Time schedule ofmodulation interventions and behavioral testing. TBI and sham animals were divided into three groups: Ctrl, SI, and SR animals. For 5 d
after TBI induction, animals received 2/d intraperitoneal saline injections (Ctrl), 2 day SO injections (400 mg/kg, i.p.; SI), or 2/d intraperitoneal saline injections plus 6 h per day gentle
handling (SR).B, Exemplary traces representing the four characterizedbehavioral states:wake,NREM, PS, andSWS-like state.C, Exemplary EEG traces showing the effect of SOadministration on EEG
and of sleep restriction on sleep rebound EEG.
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The sleep modulation procedures started the day after TBI or sham pro-
cedures and lasted 5 d (Fig. 1A). Duration of treatment was determined
by our previous studies in this model (Bu¨chele et al., 2015), in which we
detected a cognitive deficit at 7 d post-TBI, leaving a possible window for
interventions of5 d. One week was granted for washout before behav-
ioral testing.
EEG recordings and scoring. To verify the effect of sleepmodulation on
EEG spectra, we conducted bilateral EEG/EMG recordings in an addi-
tional group of TBI animals (n  15) and performed visual scoring of
acquired EEG as described previously (Bu¨chele et al., 2015).We recorded
the animals before TBI induction (baseline) and during the last 24 h of
interventions. All scoring was performed manually and the scorer was
blinded as to group. EEG and EMG were sampled at 200 Hz and signals
were amplified, filtered, and converted into analog-to-digital signals.
Hardware EMBLA and Somnologica-3 software (Medcare Flaga) were
used. Activity in the 50 Hz band was discarded from the analysis because
of power line artifacts. Power spectra of the EEG were obtained by a
discrete Fourier transformation (range: 0.75–25 Hz; frequency resolu-
tion: 0.25Hz bins; time resolution: consecutive 4 s epochs; window func-
tion: hamming). In accordance with earlier studies involving SO
treatment, we identified four behavioral states: wake, paradoxical sleep
(PS, REM), non-REM sleep (NREM), and a slow-wave sleep (SWS)-like
state induced by SO (also referred to as drug- induced state; Vienne et al.,
2010; Fig. 1B). Because the SWS-like state is characterized by predomi-
nance of low frequencies on EEG and high-amplitude waves (similar to
NREM sleep), we pooled together physiological NREM sleep and SWS-
like state for further analysis and refer to both states as SWS. Epochs were
assigned to a specific vigilance state when more than half of the epoch
fulfilled the criteria for that state. After visual scoring of acquired traces,
we exported data indicating duration of vigilance state, bout number,
and average bout duration for each behavioral state. This information
was used to calculate the fragmentation index, which is expressed as
the number of bouts/total number of epochs, with higher index values
expressing higher fragmentation of the behavioral state. Exemplary
traces of effect of SO on EEG and recovery sleep after SR are presented
in Figure 1C.
Spectral analysis. We previously excluded artifacts by visual review of
the raw data. We calculated the relative power spectral density as the
summarized power in the delta (0.5–4 Hz) frequency band for the dark
phase and light phase separately. Delta power reflects the high-
amplitude, low-frequency oscillatory activity (Tobler et al., 1997) and is
conceptualized to mirror the depth of sleep. To reduce interindividual
variability, the absolute spectral band power (in square microvolts) was
normalized to the sum of the corresponding full spectral density in each
behavioral state (1–100 Hz). All signal processing and analysis were per-
formed as described using MATLAB (The MathWorks).
Histological evaluation: immunofluorescence. DAI has been evidenced
by APP immunoreactive (APP-IR) axonal swellings (Gentleman et al.,
1993). To evaluate the effect of sleep modulation on DAI in our model,
we performed immunohistochemical analyses of APP on rat 40 m cor-
onal brain cryostat sections as described previously (Bu¨chele et al., 2015).
Briefly, we performed standard immunofluorescence staining with a
primary antibody against APP (mouse anti-APP, MAB348, 1:300; Milli-
pore), followed by secondary antibody incubation (Alexa Fluor 488-
coupled anti-mouse secondary antiserum, 1:500; Life Technologies). To
evaluate other potential mechanisms behind impairment, additional
stainings following the same protocol using UB (1:500, sc-9133; Santa
Cruz Biotechnology) and ATF-4 (an ER stress marker; 1:500, sc-200;
Santa Cruz Biotechnology) antibodies were conducted. Because these
proteins are expressed in the same time window as APP (Begum et al.,
2014), it is likely that they also play a role in the chronic functional
detriment (e.g., by increasing misfolded protein response, promoting
cell death, or decreasing protein degradation). A control experiment
using the exact same procedures except for the addition of the primary
antibody was performed to assess the degree of unspecific staining.
Fluorescent (APP) pictures were taken using a Zeiss Axio Imager M2
microscope.
Histological evaluation: APP and other protein quantifications. To de-
termine the amount of accumulated APP in cortex and hippocampus, one
experimenter blinded to experimental conditions performed APP quantifi-
cationonpreviously stained rat brain sections.AnAPP-immunoreactive cell
was defined by the presence of a positive signal both in the soma and in a
connected axon, with a length25 m. We performed a semiquantitative
analysis using a Zeiss Axio Imager M2 microscope equipped with a Ludl
MAC 6000 stage (Ludl Electronic Products) and MicroBrightField Stereo
Investigator 10.5 software (MBF Bioscience).
Wemeasured the areas of interest by tracing the outlines of cortex and
hippocampus throughout the anterior–posterior axis between 2.28
to 6.36 mm from bregma using a 2.5 objective. A grid measuring
250  250 m was superimposed and a 20 objective was used to
identify APP-IR cells within the brain areas of interest. A square within
the grid was considered as positive when at least three positive APP-IR
cells were found.We divided the total number of positive squares within
the structure studied (cortex or hippocampus) of one section by the area
of the structure, yielding a number of positive squares per square milli-
meter.We calculated the average of all analyzed sections and defined this
value as the APP trauma index (total number of positive squares per
square millimeter divided by the number of sections analyzed). To aid
visualization of the APP trauma index in hippocampus, we multiplied
the values by factor of 100,000. We used the same method for the assess-
ment of ATF-4 and UB immunoreactivity.
Results
Vigilance states proportions after sleep modulation
To confirm the effect of both sleep manipulation methods on
vigilance states (Fig. 2A), state fragmentation (Fig. 2B), and EEG
power spectra (Fig. 2C) in TBI rats, we performed EEG/EMG
recordings at baseline and during the last 24 h of sleep interven-
tions. At baseline, there was no difference in the amount of time
spent in each of the behavioral states between the groups (Ctrl, SI,
and SR) in both light and dark periods (data not shown). During
the last day of the intervention, the SR animals showed an in-
crease in time spent awake during the light period (when sleep
restriction took place; one-way ANOVA, F(2,12)  80.4, p 
0.001; TukeyHSD post hoc SR*Ctrl, p 0.001; SI*Ctrl, p 0.05).
During the dark period, both SR and SI groups spent less time
awake compared with control animals (one-way ANOVA, F(2,12)
 7.7, p  0.01; post hoc SR*Ctrl, p  0.05; SI*Ctrl, p  0.01).
Over 24 h, only the SI group spent less time awake comparedwith
controls (one-way ANOVA, F(2,12)  17.1, p  0.001; post hoc
SI*Ctrl, p 0.001). The sleep-restricted rats showed a reduction
in time spent in SWS during the light period (when SR took
place) comparedwith control animals, whereas no difference was
found between SI and Ctrl animals (one-way ANOVA, F(2,12)
23.8, p  0.001; post hoc Ctrl*SR, p  0.001; Ctrl*SI, p  0.05).
During the dark period, we observed an increase in time spent in
SWS in both SI and SR rats (sleep rebound in the latter animals;
one-way ANOVA, F(2,12) 16.1, p 0.001; post hocCtrl*SR, p
0.01; Ctrl*SI, p 0.001). Over 24 h, duration of SWS was similar
in SR and controls animals, but increased in the SI group (one-
way ANOVA, F(2,12) 12.3, p 0.01; post hoc Ctrl*SR, p 0.05;
Ctrl*SI, p 0.01). Only SR animals showed a difference in time
spent in PS, with a decrease during the light period with sleep
restriction (one-way ANOVA, F(2,12)  10.5, p  0.01; post hoc
Ctrl*SR, p  0.05) and an increase during the dark period with
sleep rebound (one-wayANOVA, F(2,12) 10.5 p 0.01; post hoc
SR*Ctrl, p 0.01; Fig. 2A).
Vigilance states fragmentation after sleep modulation
At baseline, fragmentation of vigilance states was similar in all
groups (data not shown). During the last day of sleepmodulation
in the light period, wake fragmentation index was lower in SR
animals, in contrast to SI animals, which showed increased wake
fragmentation compared with control animals (one-way
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Figure 2. Effect of sleepmodulation on vigilance states, fragmentation, and delta power after TBI. A, Proportions of vigilance states during last day of sleepmodulation (TBI only). Light period:
Only the SR group showed increase time spent awakewith subsequent decrease in time spent in SWS and PS comparedwith Ctrl (wake: p 0.001, SWS: p 0.001, PS: p 0.05). During the dark
period, both sleep-modulatedgroups showedadecrease in time spent inwake comparedwith control animals ( p0.05) andan increase in time spent in SWS ( p0.05); only theSRgroup showed
an increase in the time spent in PS ( p  0.01). Over the 24 h, only the SI group showed increased time spent in SWS ( p  0.01) and decreased time (Figure legend continues.)
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ANOVA, F(2,12) 14.6, p 0.05; post hoc
SR*Ctrl, p 0.05; SI*Ctrl, p 0.05).Dur-
ing the dark period, wake was more frag-
mented in both sleep modulation groups
compared with control animals (one-way
ANOVA, F(2,12) 10.6, p 0.01; post hoc
SR*Ctrl, p  0.05; SI*Ctrl, p  0.01). No
difference was observed in fragmentation
of SWS or PS in any of the groups (Fig.
2B).
Delta power after sleep modulation
Bothmodulated groups had an increase in
delta power proportion in the light (one-
way ANOVA, F(2,11) 5.6, p 0.05; post
hoc SR*Ctrl, p  0.05; SI*Ctrl, p  0.05)
and dark period (one-wayANOVA, F(2,11)
 7.7, p 0.01; post hocCtrl*SR, p 0.05;
Ctrl*SI, p  0.01), as well as over 24 h
(one-way ANOVA, F(2,11) 6.3, p 0.05;
post hoc SR*Ctrl, p  0.05; SI*Ctrl, p 
0.05). To aid visualization of the effect of
sleep manipulation on delta power, we
divided the 24 h recording period into
10 min bins (Fig. 2C).
Cognitive performance after acute sleep modulation
To assess the effect of sleepmodulation onTBI induced-cognitive
impairment, we performed a novel object recognition test (En-
naceur and Delacour, 1988, Bu¨chele et al., 2015). At baseline,
before trauma, all animals showed intact memory acquisition/
retrieval andperformed above the chance level (one-sample t test,
all scores compared with chance level of 0.5, p  0.05). At 14 d
after trauma, all sham groups showed preserved cognitive
abilities, as evidenced by performances above chance level. In TBI
animals, however, only the sleep-induced and sleep-restricted
groups performed above chance level, whereas control animals
evidenced impaired memory (one-sample t test, all scores com-
pared with chance level of 0.5; sham: Ctrl, SR, SI, p 0.05; TBI:
Ctrl, p 0.05; SR, SI, p 0.05; Fig. 3).
APP, UB, and ATF-4 expression after sleep modulation
To assess the effect of sleep modulation after TBI on posttrau-
matic DAI, we performed APP immunofluorescence on cortical
and hippocampal sections obtained from cryosectioned rat
brains (Fig. 4A,C). The TBI control group revealed significantly
higher APP expression than sham animals in both cortex and
hippocampus (factorial ANOVA;F(1,23) 6.1131, p 0.05). APP
quantification results showed that, compared with TBI control
animals, both sleep induction and sleep restriction resulted in
markedly lower APP expression after TBI both in cortex and
hippocampus (factorial ANOVA; F(2,23) 11.268, p 0.001; post
hoc Tukey HSD: Ctrl*SI, p 0.01; Ctrl*SR, p 0.01; Fig. 4B,D).
There was no significant difference between sham control ani-
mals and any of the sham-treated groups.
No differences were detected in immunoreactivity of ATF-4
andUB between the groups at 30 d after trauma (ATF-4: factorial
ANOVA, F(2,19).94259, p 0.05; post hoc Tukey HSD: Ctrl*SI,
p  0.05; Ctrl*SR, p  0.05; UB: factorial ANOVA, F(2,19) 
0.09273, p  0.05; post hoc Tukey HSD: Ctrl*SI, p  0.05;
Ctrl*SD, p  0.05; Fig. 4E,F). No signal was detected in the
unspecific staining controls (data not shown).
Discussion
The results of our study suggest that posttraumatic sleep modu-
lation leading to increases in delta power markedly reduces post-
traumatic APP accumulation in the cortex and hippocampus and
prevents TBI-induced cognitive impairment.
Cognitive impairment is one of the most prevalent chronic
TBI symptoms, present in up to 79% of patients (Hall et al.,
2005). Consistent with the previous reports showing posttrau-
matic memory impairment in rodents (Lyeth et al., 1990, Smith
et al., 1991, Hamm et al., 1996, Hoskison et al., 2009, Yu et al.,
2009), we found that the non-sleep-modulated TBI group devel-
oped cognitive impairment with no apparent discrimination of a
novel object after trauma. The impairment is likely mediated by
DAI, as evidenced by several observations of white matter dam-
age in human TBI patients (Inglese et al., 2005, Kraus et al., 2007)
and in rats (Li et al., 2006). After TBI, axonal transport is inter-
rupted, which results in appearance of axonal swellings, also re-
ferred to as “axonal varicosities” or “axonal bulbs” (Chen et al.,
2009). Progressive accumulation of transported material and cy-
toskeletal reorganization can result in secondary axotomy
(Christman et al., 1994) and degeneration (Raghupathi, 2004).
Moreover, an imaging study in humans revealed that white mat-
ter abnormalities in key pathways that link relevant structures
such as the frontal lobe, the hippocampal formation, or the for-
nices are linked to cognitive function after TBI (Kinnunen et al.,
4
(Figure legend continued.) spent awake (p 0.001). B, Effect of sleep modulation on frag-
mentation of behavioral states. Differences in fragmentation index (bout/epoch) were only
apparent during wake, whereas in the light period, the SR group showed more stable wake
( p  0.05) and the SI group showed more fragmented wake ( p  0.05) compared with
controls. During the dark period, both of the groups hadmore fragmentedwake comparedwith
controls (SI: p 0.01, SR: p 0.05). C, Effect of sleepmodulation on delta power. Both the SI
and SR groups had a bigger proportion of delta power during SWS in the light period ( p
0.05), dark period (SI: p 0.01, SR p 0.05), and over 24 h (SI: p 0.01, SR p 0.05)
compared with controls. Data presented in 10min bins shows dynamic changes in delta power
over the 24-h recording period.
Figure 3. Effect of sleepmodulation on cognitive performance in novel object recognition test (NORT) after TBI. All charts show
recognition index compared with chance level (0.5). Before TBI induction (baseline, BL), all animals showed intact cognitive
abilities ( p 0.05). TBI resulted in a decrease ofmemory performance at 14 d after trauma, but cognitive abilities were spared in
both the SI and SR TBI animals; the shamgroups continued performing equallywell after the surgical intervention (shamCtrl: p
0.05, sham SI: p 0.05, sham SR: p 0.05, TBI Ctrl: p 0.05, TBI SI: p 0.05, TBI SR: p 0.05).
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2011), suggesting that DAI might be a primary mechanism un-
derlying TBI-induced cognitive deficit. Indeed, we have observed
high levels of APP-immunoreactive cells in hippocampus and
cortex of non-sleep-modulated TBI animals, replicating previous
findings.
Both sleep induction with SO and sleep restriction by gentle
handling in rats within the first days after trauma appear to pre-
vent animals from developing cognitive impairment. Moreover,
both interventions led to a lower number of APP-
immunoreactive cells; that is, reduced diffuse axonal damage
compared with the control TBI group. However, at first glance, it
seems counterintuitive that pharmacological sleep induction and
sleep restriction by gentle handling would result in similar im-
provements. Based on these results and previous findings (Vi-
enne et al., 2010, Bellesi et al., 2013, Hodor et al., 2015, Plante et
al., 2015), we then hypothesized that both conditions might pro-
duce deeper sleep; that is, increased delta power. In fact, we found
that SI animals spent more time in SWS compared with the con-
trol group. The same was found in SR rats, but only in the dark
period, whereas this increase in SWS faded away over 24 h. How-
ever, the common EEG characteristic in both SI and SR animals
was an increase in delta power over 24 h. These findings are
consistent with previous findings because GHB has been shown
to promote oscillatory activity in the low-frequency (delta) range
(Entholzner et al., 1995, Meerlo et al., 2004), which is distinct
from physiological sleep (Vienne et al., 2010). Similarly, the lon-
ger somebody is being kept awake, the more frequent and larger
are this person’s slow waves during subsequent sleep (Bellesi et
Figure4. Effect of sleepmodulation on histologicalmarkers after TBI.A, C, Representative images from shamand TBI animals (all groups) showing cortical (A) and hippocampal (C) APP staining.
Only the non-sleep-modulated control TBI group showedmarked axonal staining.B,D, Quantification of APP-immunoreactive cells in cortex (B) and hippocampus (D). All charts show the number
of positive grid squares of one section dividedby the area of cortex (number of positive squares per squaremillimeter of cortex). The TBI control group shows thehighest APP trauma index (reflecting
the highest expression of APP), which is significantly different from the sham group ( p 0.05). Sleep modulation resulted in decrease of APP expression in cortex and hippocampus, as indicated
by thedecreasedAPP trauma index in the sleep-induced TBI group ( p0.01) and the sleep-restricted TBI group ( p0.01).E, Quantification of ATF-4-immunoreactive cells in cortex. Nodifference
was noted in ATF-4 immunoreactivity between the groups. F, Quantification of UB immunoreactivity in cortex. There was no difference in UB immunoreactivity between the groups.
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al., 2013). This phenomenon of strong SWS rebound after partial
sleep deprivation was also described in rats (Borbe´ly et al., 1984,
Franken et al., 1991).
It appears that slow oscillatory activity in the delta-frequency
range could be the key to functional improvement after TBI. The
mechanism behind slow-wave-facilitated improvement could be
linkedwith enhanced clearance of proteins and otherwaste prod-
ucts from interstitial space in brain. In a recent study, SWS and
ketamine–xylazine anesthesia were associated with enhanced
clearance of potentially neurotoxic waste products inmice (Xie et
al., 2013), whereas a correlation between amyloid  accumula-
tion and disruption of NREM sleep was observed in Alzheimer’s
disease patients (Mander et al., 2015), further supporting the
potential beneficial effects of enhanced slow-wave activity.
The main limitation of the present investigation is related to
relatively high within-group variability. As with many mechani-
cal injuries, the nature of TBI is very heterogeneous. However,
the behavioral variability of our model appears to correspond
well with the natural heterogeneity of human TBI despite a far
greater reproducibility of symptoms compared with the human
condition. Furthermore, our histological analyses apart from
APP were limited. Nevertheless, histological analyses of UB and
ATF-4 immunoreactivity did not yield any differences, suggest-
ing that the observed impairment is probably notmediated by ER
stress or defect in degradation, but rather that other pathophys-
iologicalmechanisms including slower accumulation rate cannot
be ruled out. Further studies will be needed to assess the cellular
effects of posttraumatic delta power enhancement to explore po-
tential mechanisms of the slow-wave-induced preservation of
cognitive abilities.
In summary, both sleep induction and sleep restriction pro-
duced enhanced delta power and preserved cognition after TBI
and prevented DAI. Interpreting our findings in the light of re-
cent studies (Kang et al., 2009, Xie et al., 2013, Mander et al.,
2015), we believe that the increase in delta power after both in-
terventions resulted in increased waste clearance, including APP,
preventing exaggerated secondary injury. Therefore, sleep mod-
ulation may constitute a novel neuroprotective approach for
treating TBI sequelae on both the cellular and symptomatic
levels.
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